Business Context and Reporting Period
This Form 8-K was filed by Artelo Biosciences, Inc. (formerly Reactive Medical Inc.) on May 2, 2017. The report details the effective date of a corporate name change previously approved by the Financial Industry Regulatory Authority (FINRA).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements.
Material Changes
- Corporate Name: Changed from Reactive Medical Inc. to Artelo Biosciences, Inc.
- Trading Symbol: Updated to "ARTL" on the Over-the-Counter Bulletin Board, effective May 2, 2017.
- CUSIP Number: Updated to 04301G102.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the administrative details of the name change.
Investor Verification Checklist
- Verify the new ticker symbol "ARTL" on the Over-the-Counter Bulletin Board.
- Confirm the new CUSIP number 04301G102 for trading and settlement purposes.
- Review the prior Form 8-K filed on April 17, 2017, for the initial announcement of the name change.